Viewing Study NCT00436657


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2026-05-19 @ 7:03 AM
Study NCT ID: NCT00436657
Status: COMPLETED
Last Update Posted: 2012-04-02
First Post: 2007-02-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peritoneal Neoplasms View
None Retroperitoneal Neoplasms View
None Gastrointestinal Neoplasms View
None Adenocarcinoma View
None Neuroblastoma View
None Ovarian Neoplasms View
None Sarcoma View
None Adrenocortical Carcinoma View
None Wilms Tumor View
None Rhabdomyosarcoma View
None Desmoplastic Small Round Cell Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Children View
None Pediatric View
None Peritoneal Tumor View
None Retroperitoneal Tumor View
None Gastrointestinal Adenocarcinoma View
None Desmoplastic Round Cell Tumor View
None Neuroblastoma View
None Ovarian Germ Cell View
None Sarcoma View
None Adrenocorticocarcinoma View
None Wilms' Tumor View
None Rhabdomyosarcoma View
None Desmoplastic Small Round Cell Tumor View
None Recurrent Tumors View
None Cisplatin View
None Platinol®-AQ View
None Platinol® View
None CDDP View
None Abdominal Wash View
None Hyperthermic Perfusion View
None Continuous Hyperthermic Peritoneal Perfusion View
None CHPP View